Literature DB >> 25918915

Maternal hypoglycemia on 50 g glucose challenge test: outcomes are influenced by fetal gender.

Hasan Onur Topçu, Can Tekin İskender, Şevki Çelen, Aslı Oskovi, Dilek Uygur, Salim Erkaya.   

Abstract

OBJECTIVE: To assess the perinatal outcomes in pregnant women with maternal hypoglycemia following a second trimester oral glucose challenge test (GCT).
MATERIALS AND METHODS: This retrospective case control study consisted of 2091 pregnant women with hypoglycemia (glucose levels >88 mg/dL 1 h following a 50 g GCT in the second trimester of pregnancy) and a control group of 2091 pregnant women with a GCT result between 88 and 130 mg/dL. Perinatal and neonatal characteristics obtained from electronic medical records were compared between groups.
RESULTS: The rates of pregnancy complications were similar in both groups, with the exception of a lower incidence of polyhydramnios and a higher rate of deliveries before the 34th week of gestation in patients with hypoglycemia (0.5% vs. 1.1%, P=0.016 vs. 2.6% vs. 1.7%, P=0.033); respectively. Neonates born to mothers with hypoglycemia had significantly less birth trauma (0.3% vs. 0.9%, P=0.027) and neonatal hypoglycemia. When the data for male and female infants were analyzed separately, male infants had a 1.5-fold (95% CI: 1.05-2.18) increased chance of being small for gestational age (SGA), whereas the risk for female infants did not increase (OR: 0.79, 95% CI: 0.56-1.11).
CONCLUSION: A low maternal plasma glucose level on the GCT is associated with favorable outcomes, such as decreased rates of birth trauma and neonatal hypoglycemia. In addition, male infants have a higher risk of being SGA than female infants when maternal GCT results were <88 mg/dL.

Entities:  

Mesh:

Year:  2016        PMID: 25918915     DOI: 10.1515/jpm-2015-0060

Source DB:  PubMed          Journal:  J Perinat Med        ISSN: 0300-5577            Impact factor:   1.901


  1 in total

1.  Flat Oral Glucose Tolerance Test During Pregnancy: Maternal Characteristics and Risk for Adverse Outcomes.

Authors:  Amir Naeh; Renana Wilkof-Segev; Anat Jaffe; Esther Maor-Sagie; Mordechai Hallak; Rinat Gabbay-Benziv
Journal:  Clin Diabetes       Date:  2021-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.